Systematic review and meta-analysis of antifungal agents for preventing fungal infections in liver transplant recipients

European Journal of Clinical Microbiology and Infectious Diseases

Volumn 25, Issue 9, 2006, Pages 549-561

  Playford, E G ^a,b   Webster, A C ^c,d   Sorrell, T C ^b   Craig, J C ^c,d  

^a PRINCESS ALEXANDRA HOSPITAL   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

^c UNIVERSITY OF SYDNEY   (Australia)

^d CHILDREN S HOSPITAL AT WESTMEAD   (Australia)

Author keywords

Antifungal; Liver transplant; Meta analysis

Indexed keywords

AMPHOTERICIN B; ANTIFUNGAL AGENT; CASPOFUNGIN; CLOTRIMAZOLE; FLUCONAZOLE; ITRACONAZOLE; NYSTATIN; PLACEBO; VORICONAZOLE;

ANTIFUNGAL ACTIVITY; CLINICAL TRIAL; DRUG EFFICACY; HIGH RISK PATIENT; HUMAN; INFECTION RISK; LIVER TRANSPLANTATION; META ANALYSIS; MYCOSIS; ORGAN TRANSPLANTATION; POSTOPERATIVE COMPLICATION; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROPHYLAXIS; RECIPIENT; REVIEW; RISK BENEFIT ANALYSIS; SYSTEMATIC REVIEW;

ANTIFUNGAL AGENTS; FLUCONAZOLE; HUMANS; LIVER TRANSPLANTATION; MYCOSES; TREATMENT OUTCOME;

EID: 33748584057     PISSN: 09349723     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10096-006-0182-3     Document Type: Review

References (54)

1. Beck-Sague C, Jarvis WR (1993) Secular trends in the epidemiology of nosocomial fungal infections in the United States, 1980-1990. J Infect Dis 167:1247-1251
2. Jarvis WR (1995) Epidemiology of nosocomial fungal infections, with emphasis on Candida species. Clin Infect Dis 20:1526-1530
3. Singh N (2000) Antifungal prophylaxis for solid organ transplant recipients: seeking clarity amidst controversy. Clin Infect Dis 31:545-553
4. Paya CV (1993) Fungal infections in solid-organ transplantation. Clin Infect Dis 16:677-688
5. Nieto-Rodriguez JA, Kusne S, Manez R, Irish W, Linden P, Magnone M, Wing EJ, Fung JJ, Starzl TE (1996) Factors associated with the development of candidemia and candidemia-related death among liver transplant recipients. Ann Surg 223:70-76
6. Husain S, Tollemar J, Dominguez EA, Baumgarten K, Humar A, Paterson DL, Wagener MM, Kusne S, Singh N (2003) Changes in the spectrum and risk factors for invasive candidiasis in liver transplant recipients: prospective, multicenter, case-controlled study. Transplantation 75:2023-2029
7. Paterson DL, Singh N (1999) Invasive aspergillosis in transplant recipients. Medicine 78:123-138
8. Lin S-J, Schranz J, Teutsch SM (2001) Aspergillosis case-fatality rate: systematic review of the literature. Clin Infect Dis 32:358-366
9. Kanda Y, Yamamoto R, Chizuka A, Hamaki T, Suguro M, Arai C, Matsuyama T, Takezako N, Miwa A, Kern W, Kami M, Akiyama H, Hirai H, Togawa A (2000) Prophylactic action of oral fluconazole against fungal infection in neutropenic patients. A meta-analysis of 16 randomized, controlled trials. Cancer 89:1611-1625
10. Bow EJ, Laverdiere M, Lussier N, Rotstein C, Cheang MS, Ioannou S (2002) Antifungal prophylaxis for severely neutropenic chemotherapy patients. A meta analysis of randomized-controlled clinical trials. Cancer 94:3230-3246
11. Glasmacher A, Prentice AG, Gorschluter M, Engelhart S, Hahn C, Djulbegovic B, Schmidt-Wolf IG (2003) Itraconazole prevents invasive fungal infections in neutropenic patients treated for hematologic malignancies: evidence from a meta-analysis of 3,597 patients. J Clin Oncol 21:4615-4626
12. Playford EG, Webster AC, Sorrell TC, Craig JC (2006) Antifungal agents for preventing fungal infections in non-neutropenic critically-ill and surgical patients: systematic review and meta-analysis of randomised clinical trials. J Antimicrob Chemother 57:628-638
13. Pappas PG, Rex JH, Sobel JD, Filler SG, Dismukes WE, Walsh TJ, Edwards JE (2004) Guidelines for treatment of candidiasis. Clin Infect Dis 38:161-189
14. Paya CV (2002) Prevention of fungal infection in transplantation. Transplant Infect Dis 4:46-51
15. Sobel JD, Rex JH (2001) Invasive candidiasis: turning risk into a practical prevention policy? Clin Infect Dis 33:187-190
16. Higgins J, Green S (2005) Highly sensitive search strategies for identifying reports of randomized controlled trials in MEDLINE. Cochrane handbook for systematic reviews of interventions 4.2.5; Section 4. The Cochrane Library, issue no. 3. Wiley, Chichester, UK
17. Lefebvre C, McDonald S (1996) Development of a sensitive search strategy for reports of randomized controlled trials in EMBASE. In: Proceedings of the 4th International Cochrane Colloquium. Cochrane Collaboration, Adelaide, Australia, Abstract no. 33
18. Higgins J, Green S (2005) Assessment of study quality. Cochrane handbook for systematic reviews of interventions 4.2.5 (updated May 2005); Section 6. The Cochrane Library, issue no. 3. Wiley, Chichester, UK
19. Ascioglu S, Rex JH, de Pauw B, Bennett JE, Bille J, Crokaert F, Denning DW, Donnelly JP, Edwards JE, Erjavec Z, Fiere D, Lortholary O, Maertens J, Meis JF, Patterson TF, Ritter J, Selleslang D, Shah PM, Stevens DA, Walsh TJ (2002) Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hemopoietic stem cell transplants: an international consensus. Clin Infect Dis 34:7-14
20. Higgins PT, Thompson SG, Deeks JJ, Altman DG (2003) Measuring inconsistency in meta-analyses. BMJ 327:557-560
21. Rossi SJ, Ferguson M, Gortesky S, Gelhoi A, Schroeder T, Hano D (1995) A randomised prospective trial of fluconazole vs. nystatin/clotrimazole for fungal prophylaxis in liver transplant recipients. In: Proceedings of the 14th Annual Meeting of the American Society of Transplant Physicians, Chicago, IL, p 149
22. Meyers B, Papanicolaou G, Chodoff L, Sheiner P, Miller C, Mendelson M, Shlasko NB (1997) A double-blind prospective controlled trial of fluconazole (F) vs. placebo in the prevention of fungal infections in patients undergoing orthotopic liver transplantation (OLT). In: Program and abstracts of the 37th ICAAC, American Society for Microbiology, Toronto, Abstract no. J57
23. Hadley S, Daly J, Pappas P, Kauffman CA, Rabkin J, Yao J, Schuster MG, Karchmer AW (2003) A randomized double-blind trial comparing AmBisome (AMB) and fluconazole (FL) in high-risk liver transplant recipients (LTR) for prevention of invasive fungal infection (IFI). In: Proceedings of the 41st Annual Meeting of the Infectious Diseases Society of America, San Diego, Abstract no. 133
24. Lumbreras C, Cuervas-Mons V, Jara P, del Palacio A, Turrion VS, Barrios C, Moreno E, Noriega AR, Paya CV (1996) Randomized trial of fluconazole versus nystatin for the prophylaxis of Candida infection following liver transplantation. J Infect Dis 174:583-588
25. Sharpe MD, Ghent C, Grant D, Horbay GLA, McDougal J, Colby WD (2003) Efficacy and safety of itraconazole prophylaxis for fungal infections after orthotopic liver transplantation: a prospective, randomized, double-blind study. Transplantation 76:977-983
26. Winston DJ, Busuttil RW (2002) Randomized controlled trial of oral itraconazole solution versus intravenous/oral fluconazole for prevention of fungal infections in liver transplant recipients. Transplantation 74:688-695
27. Tortorano AM, Viviani MA, Pagano A, Paone G, Gridelli B, Breda G, Langer M (1995) Candida colonization in orthotopic liver transplantation: fluconazole versus oral amphotericin B. J Mycol Med 5:21-24
28. Winston DJ, Pakrasi A, Busuttil RW (1999) Prophylactic fluconazole in liver transplant recipients. A randomized, double-blind, placebo-controlled trial. Ann Intern Med 131:729-737
29. Tollemar J, Hockerstedt K, Ericzon BG, Jalanko H, Ringden O (1995) Prophylaxis with liposomal amphotericin B (AmBisome) prevents fungal infections in liver transplant recipients: long-term results of a randomized, placebo-controlled trial. Transplant Proc 27:1195-1198
30. Biancofiore G, Bindi ML, Baldassarri R, Romanelli AM, Catalano G, Filipponi F, Vagelli A, Mosca F (2002) Antifungal prophylaxis in liver transplant recipients: a randomized placebo-controlled study. Transplant Int 15:341-347
31. Ruskin JD, Wood RP, Bailey MR, Whitmore CK, Shaw BW (1992) Comparative trial of oral clotrimazole and nystatin for oropharyngeal candidiasis prophylaxis in orthotopic liver transplant patients. Oral Surg Oral Med Oral Pathol 74:567-571
32. Fung JJ (2002) Fungal infection in liver transplantation. Transplant Infect Dis 4:18-23
33. Collins LA, Samore MH, Roberts MS, Luzzati R, Jenkins RL, Lewis WD, Karchmer AW (1994) Risk factors for invasive fungal infections complicating orthotopic liver transplantation. J Infect Dis 170:644-652
34. Patel R, Portela D, Badley AD, Harmsen WS, Larson-Keller JJ, Ilstrup DM, Keating MR, Wiesner RH, Krom RA, Paya CV (1996) Risk factors of invasive Candida and non-Candida fungal infections after liver transplantation. Transplantation 62:926-934
35. George MJ, Snydman DR, Werner BG, Griffith J, Falagas ME, Dougherty NN, Rubin RH (1997) The independent role of cytomegalovirus as a risk factor for invasive fungal disease in orthotopic liver transplant recipients. Am J Med 103:106-113
36. Singh N, Avery RK, Munoz P, Pruett TL, Alexander B, Jacobs R, Tollemar JG, Dominguez EA, Yu CM, Paterson DL, Husain S, Kusne S, Linden P (2003) Trends in risk profiles for and mortality associated with invasive aspergillosis among liver transplant recipients. Clin Infect Dis 36:46-52
37. Law D, Moore CB, Wardle HM, Ganguli LA, Keaney MGL, Denning DW (1994) High prevalence of antifungal resistance in Candida spp. from patients with AIDS. J Antimicrob Chemother 34:659-668
38. Johnson EM, Warnock DW, Luker J, Porter SR, Scully C (1995) Emergence of azole drug resistance in Candida species from HIV-infected patients receiving prolonged fluconazole therapy for oral candidosis. J Antimicrob Chemother 35:103-114
39. Nguyen MH, Peacock JE Jr, Morris AJ, Tanner DC, Nguyen ML, Snydman DR, Wagener MM, Rinaldi MG, Yu VL (1996) The changing face of candidemia: emergence of non-Candida albicans species and antifungal resistance. Am J Med 100:617-623
40. Abi-Said D, Anaissie E, Uzun O, Raad I, Pinzcowski H, Vartivarian S (1997) The epidemiology of hematogenous candidiasis caused by different Candida species. Clin Infect Dis 24:1122-1128
41. Fortun J, Lopez-San Roman A, Velasco JJ, Sanchez-Sousa A, de Vicente E, Nuno J, Quereda C, Barcena R, Monge G, Candela A, Honrubia A, Guerrero A (1997) Selection of Candida glabrata strains with reduced susceptibility to azoles in four liver transplant patients with invasive candidiasis. Eur J Clin Microbiol Infect Dis 16:314-318
42. Gleason TG, May AK, Caparelli D, Farr BM, Sawyer RG (1997) Emerging evidence of selection of fluconazole-tolerant fungi in surgical intensive care units. Arch Surg 132:1197-1201
43. Johansen HK, Gotzsche PC (1999) Problems in the design and reporting of trials of antifungal agents encountered during meta-analysis. JAMA 282:1752-1759
44. Smith GD, Egger M (1998) Meta-analysis: unresolved issues and future developments. BMJ 316:221-225
45. Cook DJ, Guyatt GH, Ryan G, Clifton J, Buckingham L, Willan A, McIlroy W, Oxman AD (1993) Should unpublished data be included in meta-analyses? Current convictions and controversies. JAMA 269:2749-2753
46. Thornton A, Lee P (2000) Publication bias in meta-analysis: its causes and consequences. J Clin Epidemiol 53:207-216
47. Sterling TD, Rosenbaum WL, Weinkam JJ (1995) Publication decisions revisited: the effects of the outcome of statistical tests on the decision to publish and vice versa. Am Statician 49:108-112
48. Scherer RW, Dickersin K, Langenberg P (1994) Full publication of results initially presented in abstracts. A meta-analysis. JAMA 272:158-162
49. Schultz K, Chambers I, Hayes R, Altman D (1995) Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials. JAMA 273:408-412
50. Ascioglu S, de Pauw BE, Donnelly JP, Collette L (2001) Reliability of clinical research on invasive fungal infections: a systematic review of the literature. Med Mycol 39:35-40
51. Egger M, Dickersin K, Davey Smith G (2001) Problems and limitations in conducting systematic reviews. In: Egger M, Davey Smith G, Altman DG (eds) Systematic reviews in health care. Meta-analysis in context. BMJ Publishing Group, London, pp 43-68
52. Egger M, Davey Smith G, O'Rourke K (2001) Rationale, potentials, and promise of systematic reviews. In: Egger M, Davey Smith G, Altman D (eds) Systematic reviews in health care. Meta-analysis in context. BMJ Publishing Group, London, pp 3-22
53. Deeks JJ, Altman DG, Bradburn MJ (2001) Statistical methods for examining heterogeneity and combining results from several studies in meta-analysis. In: Egger M, Davey Smith G, Altman DG (eds) Systematic reviews in health care. Meta-analysis in context. BMJ, London, pp 285-312
54. Karchmer AW, Pappas P, Merion R, Cloud G, Hadley S, Rabkin J, Schuster MG, Andes D, Kauffman C, Delaney J, Daly J, Kusne S, Alexander B (2002) Invasive fungal infection in liver transplant recipients (LTR) considered at low risk. In: Proceedings of the Infectious Diseases Society of America 40th Annual Meeting, Chicago, IL, 24-27 October 2002, Abstract no. 16